Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy

BMC Genomics

Volumn 10, Issue , 2009, Pages

  Worschech, Andrea ^a,b,c   Chen, Nanhai ^a   Yu, Yong A ^a   Zhang, Qian ^a   Pos, Zoltan ^c   Weibel, Stephanie ^a,b   Raab, Viktoria ^a,b   Sabatino, Marianna ^c   Monaco, Alessandro ^c   Liu, Hui ^c   Monsurró, Vladia ^e   Mark, R Mark ^d   Stroncek, David F ^c   Wang, Ena ^c   Szalay, Aladar A ^a,b   Marincola, Francesco M ^c  

^a GENELUX CORPORATION   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CASPASE 8; CCL1 CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CXCL9 CHEMOKINE; DIPEPTIDYL PEPTIDASE I; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR GAMMA; LYMPHOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; ONCOLYTIC VIRUS; ONCOLYTIC VIRUS GLV 1H68; PROPERDIN; RANTES; STAT1 PROTEIN; STAT3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; MICROBIAL COLONIZATION; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; TUMOR CELL; TUMOR XENOGRAFT; UPREGULATION; VACCINIA VIRUS; VIRUS REPLICATION; ANIMAL; DNA MICROARRAY; DNA SEQUENCE; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; NUDE MOUSE; TUMOR CELL LINE;

GIARDIA LAMBLIA VIRUS; VACCINIA VIRUS;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; SEQUENCE ANALYSIS, DNA; VACCINIA VIRUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67651214114     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-301     Document Type: Article

References (66)

1. Wang E Marincola FM Bottom up: A modular view of immunology Immunity 2008, 29:9-11. 10.1016/j.immuni.2008.07.002 18631452
2. Wang E Worschech A Marincola FM The immunologic constant of rejection Trends Immunol 2008, 29:256-262. 10.1016/j.it.2008.03.002 18457994
3. Hicks AM Riedlinger G Willingham MC Alexander-Miller MA von Kap-Herr C Pettenati MJ Transferable anticancer innate immunity in spontaneous regression/complete resistance mice Proc Natl Acad Sci USA 2006, 103:7753-7758. 1458507 16682640 10.1073/pnas.0602382103
4. Heise CC Williams AM Xue S Propst M Kirn DH Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy Cancer Res 1999, 59:2623-2628. 10363984
5. Gnant MF Puhlmann M Alexander HR Jr Bartlett DL Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice Cancer Res 1999, 59:3396-3403. 10416601
6. Puhlmann M Brown CK Gnant M Huang J Libutti SK Alexander HR et al Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant Cancer Gene Ther 2000. 7:66-73. 10.1038/sj.cgt.7700075 10678358
7. McCart JA Ward JM Lee J Hu Y Alexander HR Libutti SK et al Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes Cancer Res 2001, 61:8751-8757. 11751395
8. Shida H Hinuma Y Hatanaka M Morita M Kidokoro M Suzuki K et al Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene J Virol 1988, 62:4474-4480. 253556 3184271
9. Yu YA Shabahang S Timiryasova TM Zhang Q Beltz R Gentschev I et al Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins Nat Biotechnol 2004, 22:313-320. 10.1038/nbt937 14990953
10. Timiryasova TM Chen B Haghighat P Fodor I Vaccinia virus-mediated expression of wild-type p53 suppresses glioma cell growth and induces apoptosis Int J Oncol 1999, 14:845-854. 10200333
11. Tysome J Alusi G Fodor I Lemoine N Wang Y Oncolytic vaccinia virus armed with the endostatin-angiostatin fusion protein; a novel therapy for head and neck cancer Clin Otolaryngol 2008, 33:300. 10.1111/ j.1749-4486.2008.01747_5.x
12. Lattime EC Lee SS Eisenlohr LC Mastrangelo MJ In situ cytokine gene transfection using vaccinia virus vectors Semin Oncol 1996, 23:88-100. 8607035
13. Zhang Q Yu YA Wang E Chen N Danner RL Munson PJ et al Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus Cancer Res 2007, 67:10038-10046. 10.1158/0008-5472.CAN-07-0146 17942938
14. Yu YA Galanis C Woo Y Chen N Zhang Q Fong Y et al Systemically injected recombinant vaccinia virus GLV-1h68 eliminates human pancreatic tumors in nude mice Molec Cancer Ther 2008.
15. Kelly KJ Woo Y Brader P Yu Z Riedl C Lin S-H et al A novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma Hum Gene Ther 2008, 18754710
16. Lin SF Price DL Chen CH Brader P Li S Gonzalez L et al Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancer In Vivo J Clin Endocrinol Metab 2008, 93(11):4403-4407. 10.1210/jc.2008-0316 18697871
17. Roberts MS Lorence RM Groene WS Bamat MK Naturally oncolytic viruses Curr Opin Mol Ther 2006, 8:314-321. 16955694
18. Randall RE Goodbourn S Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures J Gen Virol 2008, 89:1-47. 10.1099/vir.0.83391-0 18089727
19. Worschech A Haddad D Stroncek DF Wang E Marincola FM Szalay AA The immunologic aspects of poxvirus oncolytic therapy Cancer Immunol Immunother 2009, 19266198
20. Shanker A Verdeil G Buferne M Inderberg-Suso EM Puthier D Joly F et al CD8 T cell help for innate antitumor immunity J Immunol 2007, 179:6651-6662. 17982055
21. Jones CB Clements MK Wasi S Daoud SS Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells Cancer Chemother Pharmacol 1997, 40:475-483. 10.1007/s002800050690 9332461
22. Schultz RM Merriman RL Toth JE Zimmermann JE Hertel LW Andis SL et al Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts Oncol Res 1993, 5:223-228. 8123942
23. Roschke AV Tonon G Gehlhaus KS McTyre N Bussey KJ Lababidi S et al Karyotypic complexity of the NCI-60 drug-screening panel Cancer Res 2003, 63:8634-8647. 14695175
24. Sabatino M Zhao Y Voiculescu S Monaco A Robbins PF Nickoloff BJ et al Conservation of a core of genetic alterations over a decade of recurrent melanoma supports the melanoma stem cell hypothesis Cancer Res 2008, 68:222-231. 10.1158/0008-5472.CAN-07-1939
25. Ahn WS Seo MJ Bae SM Lee JM Namkoong SE Kim CK et al Cellular process classification of human papillomavirus-16-positive SiHa cervical carcinoma cell using Gene Ontology Int J Gynecol Cancer 2005, 15:94-106. 10.1111/j.1048-891x.2005.14416.x 15670303
26. Wang E Lichtenfels R Bukur J Ngalame Y Panelli MC Seliger B et al. Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer Cancer Res 2004, 64:7279-7287. 10.1158/0008-5472.CAN-04-1597 15492247
27. Wang E Voiculescu S Le Poole IC el Gamil M Li X Sabatino M et al Clonal persistence and evolution during a decade of recurrent melanoma J Invest Dermatol 2006, 126:1372-1377. 10.1038/sj.jid.5700193 16470173
28. Guerra S Najera JL Gonzalez JM Lopez-Fernandez LA Climent N Climent N Gatell JM et al Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC J Virol 2007, 81:8707-8721. 1951336 17537851 10.1128/JVI.00444-07
29. Jin P Zhao Y Ngalame Y Panelli MC Nagorsen D Monsurro' V et al Selection and validation of endogenous reference genes using a high throughput approach BMC Genomics 2004, 5:55. 516027 15310404 10.1186/1471-2164-5-55
30. Ross DT Scherf U Eisen MB Perou CM Rees CA Spellman PT et al Systematic variation in gene expression patterns in human cancer cell lines Nature Genetics 2000, 24:227-235. 10.1038/73432 10700174
31. Wang E Miller LD Ohnmacht GA Mocellin S Petersen D Zhao Y et al Prospective molecular profiling of subcutaneous melanoma metastases suggests classifiers of immune responsiveness Cancer Res 2002, 62:3581-3586. 2241738 12097256
32. Panelli MC Stashower M Slade HB Smith K Norwood C Abati A et al Sequential gene profiling of basal cell carcinomas treated with Imiquimod in a placebo-controlled study defines the requirements for tissue rejection Genome Biol 2006, 8:R8. 10.1186/gb-2007-8-1-r8
33. Jin P Wang E Provenzano M Deola S Selleri S Jiaqiang R et al Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets J Transl Med 2006, 4: 26. 1557669 16805915 10.1186/1479-5876-4-26
34. Mantovani A Romero P Palucka AK Marincola FM Tumor immunity: Effector response to tumor and the influence of the microenvironment Lancet 2008, 371:771-783. 10.1016/S0140-6736(08)60241-X 18275997
35. Urosevic M Maier T Benninghoff B Slade H Burg G Dummer R Mechanisms unerlying imiquimod-induced regression of basal cell carcinoma in vivo Arch Dermatol 2003, 139:1325-1332. 10.1001/archderm.139.10.1325 14568837
36. Urosevic M Dummer R Conrad C Beyeler M Laine E Burg G et al Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment J Natl Cancer Inst 2005, 97:1143-1153. 16077073
37. Urosevic M Fujii K Calmels B Laine E Kobert N Acres B et al Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas J Clin Invest 2007, 117:2834-2846. 1964512 17823660 10.1172/JCI32077
38. Atkins MB Lotze MT Dutcher JP Fisher RI Weiss G Margolin K et al High-dose recombinant interleukin-2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 J Clin Oncol 1999, 17(7):2105-2116. 10561265
39. Atkins MB Regan M McDermott D Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma Clin Cancer Res 2004, 10:6342S-6346S. 10.1158/ 1078-0432.CCR-040029 15448028
40. Galon J Costes A Sanchez-Cabo F Kirilovsky A Mlecnik B et al Lagorce-Pages C Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 2006, 313:1960-1964. 10.1126/science.1129139 17008531
41. Galon J Fridman WH Pages F The adaptive immunologic microenvironment in colorectal cancer: A novel perspective Cancer Res 2007, 67:1883-1886. 10.1158/0008-5472.CAN-06-4806 17332313
42. Ramshaw IA Ramsay AJ Karupiah G Rolph MS Mahalingam S Ruby JC Cytokines and immunity to viral infections Immunol Rev 1997, 159:119-135. 10.1111/ j.1600-065X.1997.tb01011.x 9416507
43. Ochsenbein AF Klenerman P Karrer U Ludewig B Pericin M Hengartner H et al Immune suerveillance against a solid tumor fails because of immunological ignorance Proc Natl Acad Sci USA 1999, 96:2233-2238. 26766 10051624 10.1073/pnas.96.5.2233
44. Fuchs EJ Matzinger P Is cancer dangerous to the immune system? Semin Immunol 1996, 8:271-280. 10.1006/smim.1996.0035 8956455
45. Matzinger P Danger model of immunity Scand J Immunol 2001, 54:2-3. 10.1046/j.1365-3083.2001.00973.x 11439141
46. Matzinger P Friendly and dangerous signals: Is the tissue in control? Nat Immunol 2007, 8:11-13. 10.1038/ni0107-11 17179963
47. Sarwal M Chua MS Kambham N Hsieh SC Satterwhite T Masek M et al Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling N Engl J Med 2003, 349:125-138. 10.1056/ NEJMoa035588 12853585
48. Deola S Panelli MC Maric D Selleri S Dmitrieva NI Voss CY et al "Helper" B cells promote cytotoxic T cell survival and proliferation indepdently of antigen presentation through CD27-CD70 interactions J Immunol 2008, 180(3):1362-1372. 18209030
49. Worschech A Kmieciak M Knutson KL Bear HD Szalay AA Wang E et al Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors Cancer Res 2008, 68:2436-2446. 2478745 18381452 10.1158/ 0008-5472.CAN-07-6822
50. Navarro L Mowen K Rodems S Weaver B Reich N Spector D et al Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex Mol Cell Biol 1998, 18:3796-3802. 108963 9632763
51. Liu T Castro S Brasier AR Jamaluddin M Garofalo RP Casola A Reactive oxygen species mediate virus-induced STAT activation: Role of tyrosine phosphatases J Biol Chem 2004, 279:2461-2469. 10.1074/jbc.M307251200 14578356
52. Gherardi MM Ramirez JC Esteban M IL-12 and IL-18 act in synergy to clear vaccinia virus infection: Involvement of innate and adaptive components of the immune system J Gen Virol 2003, 84:1961-1972. 10.1099/ vir.0.19120-0 12867626
53. Friebe A Siegling A Friederichs S Volk HD Weber O Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: Induction of cytokine secretion in monocytes and Th1-like cells J Virol 2004, 78:9400-9411. 506965 15308734 10.1128/ JVI.78.17.9400-9411.2004
54. Tanaka-Kataoka M Kunikata T Takayama S Iwaki K Ohashi K Ikeda M et al In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection Cytokine 1999, 11:593-599. 10.1006/cyto.1998.0453 10433806
55. Zuo J Stohlman SA Bergmann CC IL-15-independent antiviral function of primary and memory CD8+ T cells Virology 2005, 331:338-348. 10.1016/ j.virol.2004.10.035 15629776
56. Perera LP Goldman CK Waldmann TA Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice Proc Natl Acad Sci USA 2001, 98:5146-5151. 33178 11296252 10.1073/pnas.081080298
57. Wang E Marincola FM A natural history of melanoma: Serial gene expression analysis Immunol Today 2000, 21:619-623. 10.1016/ S0167-5699(00)01724-2 11114422
58. Wang E Panelli MC Marincola FM Gene profiling of immune responses against tumors Curr Opin Immunol 2005, 17:423-427. 10.1016/ j.coi.2005.05.007 15950448
59. Weibel S Stritzker J Eck M Goebel W Szalay AA Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment Cell Microbiol 2008, 10:1235-1248. 10.1111/j.1462-5822.2008.01122.x 18208564
60. Wang E Miller L Ohnmacht GA Liu E Marincola FM High fidelity mRNA amplification for gene profiling using cDNA microarrays Nature Biotech 2000, 17:457-459.
61. Wang E RNA amplification for successful gene profiling analysis J Transl Med 2005, 3:28. 1201175 16042807 10.1186/1479-5876-3-28
62. Basil CF Zhao Y Zavaglia K Jin P Panelli MC Voiculescu S et al Common cancer biomarkers Cancer Res 2006, 66:2953-2961. 10.1158/ 0008-5472.CAN-05-3433 16540643
63. Simon R Lam A Li MC Ngan M Menenzes a Zhao Y Analysis of gene expression data using BRB-array tools Cancer Inform 2007, 3:11-17. 2675854 19455231
64. Eisen MB Spellman PT Brown PO Botstein D Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 1998, 95:14863-14868. 24541 9843981 10.1073/pnas.95.25.14863
65. Feldman AL Costouros NG Wang E Qian M Marincola FM Alexander HR Advantages of mRNA amplification for microarray analysis Biotechniques 2002, 33:906-914. 12398200
66. Nagorsen D Wang E Monsurro' V Zanovello P Marincola FM Panelli MC Polarized monocyte response to cytokine stimulation Genome Biol 2005, 6. 551535 15693944